This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Amunix Pharmaceuticals, Inc. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Sina Khorsand
Introduction
Sina Khorsand is an inventor based in El Cerrito, CA (US). He is known for his work in the field of biomedicine, particularly focusing on compositions that target the epidermal growth factor receptor. Although he currently holds no granted patents, his innovative ideas are reflected in his patent application.
Latest Patent Applications
Sina Khorsand's notable patent application is titled "COMPOSITIONS TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS FOR MAKING AND USING THE SAME." This application includes antibody binding domains for the cluster of differentiation 3 T cell receptor (CD3) and the epidermal growth factor receptor (EGFR). It also features cleavable linker sequences and protease-activatable bispecific fusion proteins, such as protease-activatable T cell engagers. The application outlines various uses and methods of treatment, showcasing his contributions to medical science.
Conclusion
Sina Khorsand is an emerging inventor whose work in targeting the epidermal growth factor receptor holds promise for future advancements in biomedicine. His innovative approach to antibody binding domains and fusion proteins reflects his commitment to developing effective treatment methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile